Blog

The entrepreneur reflects on his experiences in the world of biologics, winning a Nobel and his role on the bit.bio board.

Exon skipping therapy with antisense oligonucleotides is a promising therapy for DMD. This blog covers the underlying mechanisms o...

Marija Kesic, Research Assistant at bit.bio transitioned from former iGEM competitor to mentor. She discusses the role she plays i...

ALS and FTD are closely related diseases, both showing protein aggregation and axon degeneration. This blog covers similarities be...

Our CEO reflects on bit.bio's involvement in the recent 10 Downing Street discussion and launch of the engineering biology call fo...

Top tips for culturing iPSC-derived muscle cells include optimising ECM coating, optimising cell seeding density and thorough mixi...

Learn how microglia are implicated in Alzheimer's disease, and how iPSC derived microglia are changing the face of Alzheimer's res...

Celebrating World Health Day with a guest blog from the Chair of our independent Ethics and Sustainability Board Marie-Claire Cord...